Reta 32.5 mg

Kiefi pharma 

32.5 mg prefilled pen

Product Description

Looking for the cutting edge of peptide research? Retatrutide is one of the most advanced investigational compounds available today. With its unique triple-agonist action (GLP-1, GIP, and Glucagon receptors), it represents a new era in metabolic and weight-management research.

Why Researchers Choose Retatrutide:

✅ Triple receptor power – GLP-1, GIP, Glucagon pathways

✅ Metabolic innovation – fat metabolism & energy expenditure

✅ Promising body composition focus

✅ Lipidated structure for extended half-life

✅ High purity ≥99% (HPLC & MS verified)